172 related articles for article (PubMed ID: 28011212)
1. PPARβ in macrophages and atherosclerosis.
Chinetti-Gbaguidi G; Staels B
Biochimie; 2017 May; 136():59-64. PubMed ID: 28011212
[TBL] [Abstract][Full Text] [Related]
2. Unlike PPARgamma, PPARalpha or PPARbeta/delta activation does not promote human monocyte differentiation toward alternative macrophages.
Bouhlel MA; Brozek J; Derudas B; Zawadzki C; Jude B; Staels B; Chinetti-Gbaguidi G
Biochem Biophys Res Commun; 2009 Aug; 386(3):459-62. PubMed ID: 19527689
[TBL] [Abstract][Full Text] [Related]
3. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.
McLaren JE; Michael DR; Ashlin TG; Ramji DP
Prog Lipid Res; 2011 Oct; 50(4):331-47. PubMed ID: 21601592
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor mediated mechanisms of macrophage cholesterol metabolism.
Nagy ZS; Czimmerer Z; Nagy L
Mol Cell Endocrinol; 2013 Apr; 368(1-2):85-98. PubMed ID: 22546548
[TBL] [Abstract][Full Text] [Related]
5. Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis.
Chen FY; Zhou J; Guo N; Ma WG; Huang X; Wang H; Yuan ZY
Biochem Biophys Res Commun; 2015 Nov; 467(4):872-8. PubMed ID: 26471308
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state.
Adhikary T; Wortmann A; Schumann T; Finkernagel F; Lieber S; Roth K; Toth PM; Diederich WE; Nist A; Stiewe T; Kleinesudeik L; Reinartz S; Müller-Brüsselbach S; Müller R
Nucleic Acids Res; 2015 May; 43(10):5033-51. PubMed ID: 25934804
[TBL] [Abstract][Full Text] [Related]
7. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
8. Lipid ligand-activated transcription factors regulating lipid storage and release in human macrophages.
Chinetti-Gbaguidi G; Staels B
Biochim Biophys Acta; 2009 Jun; 1791(6):486-93. PubMed ID: 19416654
[TBL] [Abstract][Full Text] [Related]
9. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
Wagner KD; Wagner N
Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
[TBL] [Abstract][Full Text] [Related]
11. Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.
Karunakaran D; Thrush AB; Nguyen MA; Richards L; Geoffrion M; Singaravelu R; Ramphos E; Shangari P; Ouimet M; Pezacki JP; Moore KJ; Perisic L; Maegdefessel L; Hedin U; Harper ME; Rayner KJ
Circ Res; 2015 Jul; 117(3):266-78. PubMed ID: 26002865
[TBL] [Abstract][Full Text] [Related]
12. Macrophage Phenotype and Function in Different Stages of Atherosclerosis.
Tabas I; Bornfeldt KE
Circ Res; 2016 Feb; 118(4):653-67. PubMed ID: 26892964
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation.
Bishop-Bailey D; Bystrom J
Pharmacol Ther; 2009 Nov; 124(2):141-50. PubMed ID: 19615407
[TBL] [Abstract][Full Text] [Related]
14. Effects of peroxisome proliferator-activated receptor-β/δ on sepsis induced acute lung injury.
Wang C; Zhou G; Zeng Z
Chin Med J (Engl); 2014; 127(11):2129-37. PubMed ID: 24890166
[TBL] [Abstract][Full Text] [Related]
15. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
16. Conversion of human M-CSF macrophages into foam cells reduces their proinflammatory responses to classical M1-polarizing activation.
da Silva RF; Lappalainen J; Lee-Rueckert M; Kovanen PT
Atherosclerosis; 2016 May; 248():170-8. PubMed ID: 27038418
[TBL] [Abstract][Full Text] [Related]
17. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis.
Chen HH; Keyhanian K; Zhou X; Vilmundarson RO; Almontashiri NA; Cruz SA; Pandey NR; Lerma Yap N; Ho T; Stewart CA; Huang H; Hari A; Geoffrion M; McPherson R; Rayner KJ; Stewart AF
Circ Res; 2015 Sep; 117(8):671-83. PubMed ID: 26195219
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
[TBL] [Abstract][Full Text] [Related]
19. The role of peroxisome proliferator-activated receptor γ in lipid metabolism and inflammation in atherosclerosis.
Yang XF; Shang DJ
Cell Biol Int; 2023 Sep; 47(9):1469-1487. PubMed ID: 37369936
[TBL] [Abstract][Full Text] [Related]
20. Activation of peroxisome proliferator-activated receptor δ inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein.
Bojic LA; Sawyez CG; Telford DE; Edwards JY; Hegele RA; Huff MW
Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2919-28. PubMed ID: 23023367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]